The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.

GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for the continued development and ...

The US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir).

AstraZeneca is the latest pharma company enlisting the services of Chinese biotechs, signing a deal worth up to $5.2bn with ...

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

Late-stage pipeline products can generate demand in the MG market and with diagnosed prevalent cases, will drive growth in ...

The future of US immunisation is up in the air as outspoken critics of vaccines populate an integral recommendation committee ...

Antares Therapeutics has secured $177m in Series A financing round for the development of precision medicines.

Decreasing CD4 and lymphocyte counts in some participants receiving an oral combination therapy led to holds in the study.

BioNTech has agreed to acquire CureVac for approximately $1.25bn, as the former amps up its strategy to offer cancer ...

SpliceBio has closed a Series B financing round, raising $135m for the clinical development of SB-007 for Stargardt disease.

MSD has received FDA approval for Enflonsia (clesrovimab-cfor) to prevent respiratory syncytial virus (RSV) in neonates and ...